Inventiva seeks FDA approval for lanifibranor in the U.S. market.
3 reports, 2 independent
Updated Oct 1
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Inventiva seeks FDA approval for lanifibranor in the U.S. market.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.INVENTIVA is developing a late-stage drug candidate for MASH.1 source
Inventiva filed for FDA approval of lanifibranor.1 source
Keep exploring
The entities involved
Related events
- Arise is seeking FDA approval for a drug as of October 7, 2026.
- FDA and Pfizer are seeking regulatory approval for their products.
- Generic medicine services are seeking approval for launch from the FDA.
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- FDA approval enables commercial availability for a product associated with Indianapolis.